Last time I interviewed BioViva CEO Liz Parrish I had no idea that she would make global headlines shortly thereafter by becoming a gene therapy test subject herself. And so I wanted to bring her back to discuss the kind of experiment she volunteered for, as well as the broad science behind it. So, 4 months after receiving gene therapies aimed at reversing muscle-wasting disease and aging, I finally managed to get Liz on my Singularity 1on1 podcast.
During our 60 min conversation with Liz Parrish we cover a variety of interesting topics such as: why she decided to target these particular diseases – sarcopenia and aging; why Parrish thinks that testing them both at once is a good thing; the best and worst case outcome scenarios; the potential bio-markers that can confirm or deny the efficacy of these therapies; the test protocol and timeline for any definitive results; the costs associated with such treatments and why insurance companies and governments will have an incentive to pay; Zoltan Istvan’s presidential candidacy and his campaign against death; her take on CRISPR and gene editing…
You can watch the full video here: https://www.singularityweblog.com/bioviva-ceo-liz-parrish-on-becoming-gene-therapy-test-subject/
